M. Varini
- Cancer Research top 10%
-
- Chemotherapy-induced organ toxicity mitigation 3
- Oncology top 10%
- Cancer Treatment and Pharmacology 5
- Lung Cancer Research Studies 2
-
- Chronic Myeloid Leukemia Treatments 2
-
- Cancer therapeutics and mechanisms 5
- Renal and related cancers 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 3
-
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- W. BradeF. CavalliPinuccia ValagussaDario RoviniGianni BonadonnaM. De LenaR ZucaliG Viganotti
- Partner nations
- SwitzerlandItalyAustria
In The Last Decade
M. Varini
18 papers receiving 613 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 201
- Pathology and Forensic Medicine 240
- Oncology 319
- Pulmonary and Respiratory Medicine 184
- Hematology 62
Countries citing papers authored by M. Varini
This map shows the geographic impact of M. Varini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Varini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Varini more than expected).
Fields of papers citing papers by M. Varini
This network shows the impact of papers produced by M. Varini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Varini. The network helps show where M. Varini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Varini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 1993 | 24 | |
| 3 | [Aortic valvular dysplasia in a dog]. | 1989 | 1 |
| 4 | 1985 | 19 | |
| 5 | 1985 | 201 | |
| 6 | [Effect of interferon-alpha 2 (E. coli) in hairy cell leukemia]. | 1985 | 7 |
| 7 | High-dose ifosfamide in advanced osteosarcoma. | 1985 | 74 |
| 8 | 1984 | 8 | |
| 9 | 1984 | 13 | |
| 10 | 1983 | 55 | |
| 11 | 1983 | 50 | |
| 12 | 1983 | 5 | |
| 13 | [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma]. | 1982 | 2 |
| 14 | 1982 | 22 | |
| 15 | 1982 | 6 | |
| 16 | 1982 | 25 | |
| 17 | Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. | 1981 | 123 |
| 18 | 1979 | 1 |
About M. Varini
M. Varini is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Hematology and Cancer Research, having authored 18 papers that have together received 646 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Renal and related cancers (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Cancer Research (201 citations), Pathology and Forensic Medicine (240 citations), Oncology (319 citations), Pulmonary and Respiratory Medicine (184 citations) and Hematology (62 citations). M. Varini has collaborated with scholars based in Switzerland, Italy and Austria. Frequent co-authors include W. Brade, F. Cavalli, Pinuccia Valagussa, Dario Rovini, Gianni Bonadonna, M. De Lena, R Zucali, G Viganotti, Umberto Veronesi and Paul T. Kröner. Their work appears in journals such as Cancer Treatment Reviews, Cancer, Investigational New Drugs, Annals of Oncology and BMC Palliative Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.